Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026
Does Omnicell’s Revenue Beat and Weak EBITDA Guidance Change The Bull Case For OMCL?
Healthcare Technology for Providers Stocks Q2 Recap: Benchmarking Omnicell (NASDAQ:OMCL)
Omnicell (OMCL) Stock Trades Below Fair Value After A 78% Slump
3 Reasons OMCL is Risky and 1 Stock to Buy Instead
TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations
Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference
Three Earnings Reports Put the Automation Rally to the Test
Omnicell President Sells 6,753 Shares
OMCL Falls 20.1% in a Month as Booking and Margin Risks Build
Omnicell (OMCL) Is Down 12.5% After Raising 2026 Revenue Outlook And Returning To Profitability
Omnicell (OMCL) Stock May Be 42% Below Fair Value On Weak Guidance
Piper Sandler Reiterates Overweight on Omnicell, Lowers Price Target to $45
OMCL Q2 Earnings Call Highlights Titan XT Pipeline Growth
Wells Fargo Maintains Overweight on Omnicell, Lowers Price Target to $50
Keybanc Maintains Overweight on Omnicell, Lowers Price Target to $65
Omnicell (OMCL) Stock Trades Down, Here Is Why
Omnicell Inc (OMCL) (Q2 2026) Earnings Call Highlights: Strong Profitability and Strategic Wins ...
Omnicell Q2 Earnings Call Highlights
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.